Menorrhagia and minor bleeding symptoms in women on oral anticoagulation.
(2007) In Journal of Thrombosis and Thrombolysis 24(1). p.39-41- Abstract
- Background Oral anticoagulation (OA) is a common treatment with a known risk of fatal or major bleeding, but also minor bleeding symptoms and menorrhagia can cause substantial discomfort and necessitate medical or surgical interventions. The extent of these side effects is however not previously reported. The objective of this study is to assess the frequency of minor bleeding symptoms and menorrhagia attributed to OA treatment.
Methods Ninety fertile women between 15 and 49 years-of-age on OA treatment completed an inquiry at the anticoagulation clinics of Malmö, Lund and Gothenburg, Sweden.
Results The frequency of minor bleeding symptoms was significantly increased during OA treatment (P < 0.05) except for... (More) - Background Oral anticoagulation (OA) is a common treatment with a known risk of fatal or major bleeding, but also minor bleeding symptoms and menorrhagia can cause substantial discomfort and necessitate medical or surgical interventions. The extent of these side effects is however not previously reported. The objective of this study is to assess the frequency of minor bleeding symptoms and menorrhagia attributed to OA treatment.
Methods Ninety fertile women between 15 and 49 years-of-age on OA treatment completed an inquiry at the anticoagulation clinics of Malmö, Lund and Gothenburg, Sweden.
Results The frequency of minor bleeding symptoms was significantly increased during OA treatment (P < 0.05) except for hematuria. The incidence of bleeding after tooth extraction (>3 h) increased from 3.0 to 45.2%, easy bruising 17.8–75.6%, epistaxis 11.1–23.6%, gingival bleeding 22.2–48.3% and hematuria 10.0–15.6% (Table 1). Hematemesis was reported in 5.6% prior to as compared to 14.4% during OA treatment, blood in the feces in 8.9 and 18.9%, respectively. Mean duration of menses increased from 5.6 to 6.1 days (P < 0.01) and reported menorrhagia from 44.2 to 70.8% (P < 0.001). Eighteen percent were treated for menorrhagia before and 29.9% during OA treatment (P < 0.01).
Conclusions OA treatment is known to confer increased risk of fatal or major bleeding. This study shows that fertile women on OA also experience significantly increased minor bleeding symptoms including menorrhagia that may considerably impair quality of life. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/164581
- author
- Själander, Anders ; Friberg, Britt LU ; Svensson, Peter LU ; Stigendal, Lennart and Lethagen, Stefan LU
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Minor bleeding symptoms, Menorrhagia, Warfarin, Oral anticoagulation
- in
- Journal of Thrombosis and Thrombolysis
- volume
- 24
- issue
- 1
- pages
- 39 - 41
- publisher
- Springer
- external identifiers
-
- wos:000246585500006
- scopus:34249679559
- pmid:17260163
- ISSN
- 1573-742X
- DOI
- 10.1007/s11239-006-0003-7
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200), Department of Obstetrics and Gynaecology (Lund) (013018000), Clinical Coagulation Research Unit (013242510)
- id
- e85d657d-cc53-4a28-99e8-46df5635653e (old id 164581)
- date added to LUP
- 2016-04-01 15:32:52
- date last changed
- 2022-03-30 01:52:50
@article{e85d657d-cc53-4a28-99e8-46df5635653e,
abstract = {{Background Oral anticoagulation (OA) is a common treatment with a known risk of fatal or major bleeding, but also minor bleeding symptoms and menorrhagia can cause substantial discomfort and necessitate medical or surgical interventions. The extent of these side effects is however not previously reported. The objective of this study is to assess the frequency of minor bleeding symptoms and menorrhagia attributed to OA treatment.<br/><br>
Methods Ninety fertile women between 15 and 49 years-of-age on OA treatment completed an inquiry at the anticoagulation clinics of Malmö, Lund and Gothenburg, Sweden.<br/><br>
Results The frequency of minor bleeding symptoms was significantly increased during OA treatment (P < 0.05) except for hematuria. The incidence of bleeding after tooth extraction (>3 h) increased from 3.0 to 45.2%, easy bruising 17.8–75.6%, epistaxis 11.1–23.6%, gingival bleeding 22.2–48.3% and hematuria 10.0–15.6% (Table 1). Hematemesis was reported in 5.6% prior to as compared to 14.4% during OA treatment, blood in the feces in 8.9 and 18.9%, respectively. Mean duration of menses increased from 5.6 to 6.1 days (P < 0.01) and reported menorrhagia from 44.2 to 70.8% (P < 0.001). Eighteen percent were treated for menorrhagia before and 29.9% during OA treatment (P < 0.01).<br/><br>
Conclusions OA treatment is known to confer increased risk of fatal or major bleeding. This study shows that fertile women on OA also experience significantly increased minor bleeding symptoms including menorrhagia that may considerably impair quality of life.}},
author = {{Själander, Anders and Friberg, Britt and Svensson, Peter and Stigendal, Lennart and Lethagen, Stefan}},
issn = {{1573-742X}},
keywords = {{Minor bleeding symptoms; Menorrhagia; Warfarin; Oral anticoagulation}},
language = {{eng}},
number = {{1}},
pages = {{39--41}},
publisher = {{Springer}},
series = {{Journal of Thrombosis and Thrombolysis}},
title = {{Menorrhagia and minor bleeding symptoms in women on oral anticoagulation.}},
url = {{http://dx.doi.org/10.1007/s11239-006-0003-7}},
doi = {{10.1007/s11239-006-0003-7}},
volume = {{24}},
year = {{2007}},
}